دورية أكاديمية
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases
العنوان: | Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases |
---|---|
المؤلفون: | Nguyen, Q. D. and De Falco, S. and Behar-Cohen, F. and Lam, W. -C. and Li, X. and Reichhart, N. and Ricci, F. and Pluim, J. and Li, W. W. Nguyen, QD, De Falco, S, Behar-Cohen, F, Lam, WC, Li, X, Reichhart, N, Ricci, F, Pluim, J, Li, WW |
المساهمون: | Nguyen, Q. D., Adf, S., Ab, F., Al, W. -C., Al, X., Ar, N., Ar, F., Ap, J., Al, W. W., N, Qd, De Falco, S, Behar-Cohen, F, Lam, W, Li, X, Reichhart, N, Ricci, F, Pluim, J, Li, W |
بيانات النشر: | Blackwell Publishing Ltd |
سنة النشر: | 2018 |
المجموعة: | Universitá degli Studi di Roma "Tor Vergata": ART - Archivio Istituzionale della Ricerca |
مصطلحات موضوعية: | aflibercept, bevacizumab, placental growth factor, ranibizumab, vasculotropin A, vasculotropin B, vasculotropin inhibitor, vasculotropin receptor 1, vasculotropin receptor 2, age related macular degeneration, clinical outcome, clinical research, comparative effectivene, diabetic macular edema, diabetic retinopathy, drug efficacy, drug safety, drug targeting, eye disease, gold standard, heart infarction, human, microangiopathy, nonhuman, ocular neovascular disease, priority journal, protein binding, protein domain, protein function, protein synthesi |
الوصف: | The role of vascular endothelial growth factor (VEGF), including in retinal vascular diseases, has been well studied, and pharmacological blockade of VEGF is the gold standard of treatment for neovascular age-related macular degeneration, retinal vein occlusion and diabetic macular oedema. Placental growth factor (PGF, previously known as PlGF), a homologue of VEGF, is a multifunctional peptide associated with angiogenesis-dependent pathologies in the eye and non-ocular conditions. Animal studies using genetic modification and pharmacological treatment have demonstrated a mechanistic role for PGF in pathological angiogenesis. Inhibition decreases neovascularization and microvascular abnormalities across different models, including oxygen-induced retinopathy, laser-induced choroidal neovascularization and in diabetic mice exhibiting retinopathies. High levels of PGF have been found in the vitreous of patients with diabetic retinopathy. Despite these strong animal data, the exact role of PGF in pathological angiogenesis in retinal vascular diseases remains to be defined, and the benefits of PGF-specific inhibition in humans with retinal neovascular diseases and macular oedema remain controversial. Comparative effectiveness research studies in patients with diabetic retinal disease have shown that treatment that inhibits both VEGF and PGF may provide superior outcomes in certain patients compared with treatment that inhibits only VEGF. This review summarizes current knowledge of PGF, including its relationship to VEGF and its role in pathological angiogenesis in retinal diseases, and identifies some key unanswered questions about PGF that can serve as a pathway for future basic, translational and clinical research. © 2016 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation and European Association for Vision & Eye Research. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
العلاقة: | info:eu-repo/semantics/altIdentifier/wos/WOS:000423066600001; volume:96; issue:1; firstpage:e1; lastpage:e9; journal:ACTA OPHTHALMOLOGICA; http://hdl.handle.net/2108/242449Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85006078289; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006078289&doi=10.1111/aos.13325&partnerID=40&md5=87503c4e9fdcd0cfe2727cf7bffee5a0Test |
DOI: | 10.1111/aos.13325 |
DOI: | 10.1111/aos.13325&partnerID=40&md5=87503c4e9fdcd0cfe2727cf7bffee5a0 |
الإتاحة: | https://doi.org/10.1111/aos.13325Test http://hdl.handle.net/2108/242449Test |
رقم الانضمام: | edsbas.F1C75B88 |
قاعدة البيانات: | BASE |
ResultId |
1 |
---|---|
Header |
edsbas BASE edsbas.F1C75B88 821 3 Academic Journal academicJournal 821.334289550781 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.F1C75B88&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doi.org/10.1111/aos.13325# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Nguyen%22">Nguyen</searchLink><br /><searchLink fieldCode="AR" term="%22Q%2E+D%2E+and+De+Falco%22">Q. D. and De Falco</searchLink><br /><searchLink fieldCode="AR" term="%22S%2E+and+Behar-Cohen%22">S. and Behar-Cohen</searchLink><br /><searchLink fieldCode="AR" term="%22F%2E+and+Lam%22">F. and Lam</searchLink><br /><searchLink fieldCode="AR" term="%22W%2E+-C%2E+and+Li%22">W. -C. and Li</searchLink><br /><searchLink fieldCode="AR" term="%22X%2E+and+Reichhart%22">X. and Reichhart</searchLink><br /><searchLink fieldCode="AR" term="%22N%2E+and+Ricci%22">N. and Ricci</searchLink><br /><searchLink fieldCode="AR" term="%22F%2E+and+Pluim%22">F. and Pluim</searchLink><br /><searchLink fieldCode="AR" term="%22J%2E+and+Li%22">J. and Li</searchLink><br /><searchLink fieldCode="AR" term="%22W%2E+W%2E+Nguyen%22">W. W. Nguyen</searchLink><br /><searchLink fieldCode="AR" term="%22QD%22">QD</searchLink><br /><searchLink fieldCode="AR" term="%22De+Falco%2C+S%22">De Falco, S</searchLink><br /><searchLink fieldCode="AR" term="%22Behar-Cohen%2C+F%22">Behar-Cohen, F</searchLink><br /><searchLink fieldCode="AR" term="%22Lam%2C+WC%22">Lam, WC</searchLink><br /><searchLink fieldCode="AR" term="%22Li%2C+X%22">Li, X</searchLink><br /><searchLink fieldCode="AR" term="%22Reichhart%2C+N%22">Reichhart, N</searchLink><br /><searchLink fieldCode="AR" term="%22Ricci%2C+F%22">Ricci, F</searchLink><br /><searchLink fieldCode="AR" term="%22Pluim%2C+J%22">Pluim, J</searchLink><br /><searchLink fieldCode="AR" term="%22Li%2C+WW%22">Li, WW</searchLink> ) Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Nguyen<br />Q. D., Adf<br />S., Ab<br />F., Al<br />W. -C., Al<br />X., Ar<br />N., Ar<br />F., Ap<br />J., Al<br />W. W., N<br />Qd<br />De Falco, S<br />Behar-Cohen, F<br />Lam, W<br />Li, X<br />Reichhart, N<br />Ricci, F<br />Pluim, J<br />Li, W ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Blackwell Publishing Ltd ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2018 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Universitá degli Studi di Roma "Tor Vergata": ART - Archivio Istituzionale della Ricerca ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22aflibercept%22">aflibercept</searchLink><br /><searchLink fieldCode="DE" term="%22bevacizumab%22">bevacizumab</searchLink><br /><searchLink fieldCode="DE" term="%22placental+growth+factor%22">placental growth factor</searchLink><br /><searchLink fieldCode="DE" term="%22ranibizumab%22">ranibizumab</searchLink><br /><searchLink fieldCode="DE" term="%22vasculotropin+A%22">vasculotropin A</searchLink><br /><searchLink fieldCode="DE" term="%22vasculotropin+B%22">vasculotropin B</searchLink><br /><searchLink fieldCode="DE" term="%22vasculotropin+inhibitor%22">vasculotropin inhibitor</searchLink><br /><searchLink fieldCode="DE" term="%22vasculotropin+receptor+1%22">vasculotropin receptor 1</searchLink><br /><searchLink fieldCode="DE" term="%22vasculotropin+receptor+2%22">vasculotropin receptor 2</searchLink><br /><searchLink fieldCode="DE" term="%22age+related+macular+degeneration%22">age related macular degeneration</searchLink><br /><searchLink fieldCode="DE" term="%22clinical+outcome%22">clinical outcome</searchLink><br /><searchLink fieldCode="DE" term="%22clinical+research%22">clinical research</searchLink><br /><searchLink fieldCode="DE" term="%22comparative+effectivene%22">comparative effectivene</searchLink><br /><searchLink fieldCode="DE" term="%22diabetic+macular+edema%22">diabetic macular edema</searchLink><br /><searchLink fieldCode="DE" term="%22diabetic+retinopathy%22">diabetic retinopathy</searchLink><br /><searchLink fieldCode="DE" term="%22drug+efficacy%22">drug efficacy</searchLink><br /><searchLink fieldCode="DE" term="%22drug+safety%22">drug safety</searchLink><br /><searchLink fieldCode="DE" term="%22drug+targeting%22">drug targeting</searchLink><br /><searchLink fieldCode="DE" term="%22eye+disease%22">eye disease</searchLink><br /><searchLink fieldCode="DE" term="%22gold+standard%22">gold standard</searchLink><br /><searchLink fieldCode="DE" term="%22heart+infarction%22">heart infarction</searchLink><br /><searchLink fieldCode="DE" term="%22human%22">human</searchLink><br /><searchLink fieldCode="DE" term="%22microangiopathy%22">microangiopathy</searchLink><br /><searchLink fieldCode="DE" term="%22nonhuman%22">nonhuman</searchLink><br /><searchLink fieldCode="DE" term="%22ocular+neovascular+disease%22">ocular neovascular disease</searchLink><br /><searchLink fieldCode="DE" term="%22priority+journal%22">priority journal</searchLink><br /><searchLink fieldCode="DE" term="%22protein+binding%22">protein binding</searchLink><br /><searchLink fieldCode="DE" term="%22protein+domain%22">protein domain</searchLink><br /><searchLink fieldCode="DE" term="%22protein+function%22">protein function</searchLink><br /><searchLink fieldCode="DE" term="%22protein+synthesi%22">protein synthesi</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => The role of vascular endothelial growth factor (VEGF), including in retinal vascular diseases, has been well studied, and pharmacological blockade of VEGF is the gold standard of treatment for neovascular age-related macular degeneration, retinal vein occlusion and diabetic macular oedema. Placental growth factor (PGF, previously known as PlGF), a homologue of VEGF, is a multifunctional peptide associated with angiogenesis-dependent pathologies in the eye and non-ocular conditions. Animal studies using genetic modification and pharmacological treatment have demonstrated a mechanistic role for PGF in pathological angiogenesis. Inhibition decreases neovascularization and microvascular abnormalities across different models, including oxygen-induced retinopathy, laser-induced choroidal neovascularization and in diabetic mice exhibiting retinopathies. High levels of PGF have been found in the vitreous of patients with diabetic retinopathy. Despite these strong animal data, the exact role of PGF in pathological angiogenesis in retinal vascular diseases remains to be defined, and the benefits of PGF-specific inhibition in humans with retinal neovascular diseases and macular oedema remain controversial. Comparative effectiveness research studies in patients with diabetic retinal disease have shown that treatment that inhibits both VEGF and PGF may provide superior outcomes in certain patients compared with treatment that inhibits only VEGF. This review summarizes current knowledge of PGF, including its relationship to VEGF and its role in pathological angiogenesis in retinal diseases, and identifies some key unanswered questions about PGF that can serve as a pathway for future basic, translational and clinical research. © 2016 The Authors. Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation and European Association for Vision & Eye Research. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => info:eu-repo/semantics/altIdentifier/wos/WOS:000423066600001; volume:96; issue:1; firstpage:e1; lastpage:e9; journal:ACTA OPHTHALMOLOGICA; http://hdl.handle.net/2108/242449; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85006078289; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006078289&doi=10.1111/aos.13325&partnerID=40&md5=87503c4e9fdcd0cfe2727cf7bffee5a0 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1111/aos.13325 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1111/aos.13325&partnerID=40&md5=87503c4e9fdcd0cfe2727cf7bffee5a0 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1111/aos.13325<br />http://hdl.handle.net/2108/242449 ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.F1C75B88 ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1111/aos.13325
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => aflibercept
[Type] => general
)
[1] => Array
(
[SubjectFull] => bevacizumab
[Type] => general
)
[2] => Array
(
[SubjectFull] => placental growth factor
[Type] => general
)
[3] => Array
(
[SubjectFull] => ranibizumab
[Type] => general
)
[4] => Array
(
[SubjectFull] => vasculotropin A
[Type] => general
)
[5] => Array
(
[SubjectFull] => vasculotropin B
[Type] => general
)
[6] => Array
(
[SubjectFull] => vasculotropin inhibitor
[Type] => general
)
[7] => Array
(
[SubjectFull] => vasculotropin receptor 1
[Type] => general
)
[8] => Array
(
[SubjectFull] => vasculotropin receptor 2
[Type] => general
)
[9] => Array
(
[SubjectFull] => age related macular degeneration
[Type] => general
)
[10] => Array
(
[SubjectFull] => clinical outcome
[Type] => general
)
[11] => Array
(
[SubjectFull] => clinical research
[Type] => general
)
[12] => Array
(
[SubjectFull] => comparative effectivene
[Type] => general
)
[13] => Array
(
[SubjectFull] => diabetic macular edema
[Type] => general
)
[14] => Array
(
[SubjectFull] => diabetic retinopathy
[Type] => general
)
[15] => Array
(
[SubjectFull] => drug efficacy
[Type] => general
)
[16] => Array
(
[SubjectFull] => drug safety
[Type] => general
)
[17] => Array
(
[SubjectFull] => drug targeting
[Type] => general
)
[18] => Array
(
[SubjectFull] => eye disease
[Type] => general
)
[19] => Array
(
[SubjectFull] => gold standard
[Type] => general
)
[20] => Array
(
[SubjectFull] => heart infarction
[Type] => general
)
[21] => Array
(
[SubjectFull] => human
[Type] => general
)
[22] => Array
(
[SubjectFull] => microangiopathy
[Type] => general
)
[23] => Array
(
[SubjectFull] => nonhuman
[Type] => general
)
[24] => Array
(
[SubjectFull] => ocular neovascular disease
[Type] => general
)
[25] => Array
(
[SubjectFull] => priority journal
[Type] => general
)
[26] => Array
(
[SubjectFull] => protein binding
[Type] => general
)
[27] => Array
(
[SubjectFull] => protein domain
[Type] => general
)
[28] => Array
(
[SubjectFull] => protein function
[Type] => general
)
[29] => Array
(
[SubjectFull] => protein synthesi
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Nguyen
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Q. D. and De Falco
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => S. and Behar-Cohen
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => F. and Lam
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => W. -C. and Li
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => X. and Reichhart
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => N. and Ricci
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => F. and Pluim
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => J. and Li
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => W. W. Nguyen
)
)
)
[10] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => QD
)
)
)
[11] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => De Falco, S
)
)
)
[12] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Behar-Cohen, F
)
)
)
[13] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Lam, WC
)
)
)
[14] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Li, X
)
)
)
[15] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Reichhart, N
)
)
)
[16] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ricci, F
)
)
)
[17] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Pluim, J
)
)
)
[18] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Li, WW
)
)
)
[19] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Nguyen
)
)
)
[20] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Q. D., Adf
)
)
)
[21] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => S., Ab
)
)
)
[22] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => F., Al
)
)
)
[23] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => W. -C., Al
)
)
)
[24] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => X., Ar
)
)
)
[25] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => N., Ar
)
)
)
[26] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => F., Ap
)
)
)
[27] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => J., Al
)
)
)
[28] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => W. W., N
)
)
)
[29] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Qd
)
)
)
[30] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => De Falco, S
)
)
)
[31] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Behar-Cohen, F
)
)
)
[32] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Lam, W
)
)
)
[33] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Li, X
)
)
)
[34] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Reichhart, N
)
)
)
[35] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ricci, F
)
)
)
[36] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Pluim, J
)
)
)
[37] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Li, W
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2018
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
)
)
)
)
)
)
|
IllustrationInfo |